HOME >> MEDICINE >> NEWS
Review identifies factors leading to better outcome for some metastatic breast cancer patients

DURHAM, N.C.--Duke University Medical Center researchers have identified a subset of patients with advanced breast cancer who had greater success than other patients treated with experimental high-dose chemotherapy followed by bone marrow transplant.

In a retrospective review of a previous Duke study of 425 patients, now with an average of six years' follow-up, of the 299 patients who had high-dose chemotherapy with transplant, those patients who had previously received hormone therapy with the drug tamoxifen, but had not previously received chemotherapy and had no tumors beyond the chest wall and lymph nodes were more likely to live longer than the other patients.

The findings of the Duke study, published in the October Journal of Clinical Oncology, can help physicians select which metastatic breast cancer patients might benefit most from aggressive therapy and suggest restructuring follow-up treatment for patients at high risk for recurrence or new spread of disease, according to the authors.

"Right now high-risk patients are followed with a symptom-based approach--if there's a problem or change in symptoms then tests are done to see why," said lead author Dr. David Rizzieri. "Instead, at-risk patients should be followed very closely, with routinely scheduled physical, radiographic and laboratory tests to catch recurrence early, before symptoms appear. We want to hit the disease early, and hit it hard."

Because of its greater toxicity and a dearth of clinical trials comparing it to standard treatments, high-dose chemotherapy with bone marrow transplant is a controversial treatment for breast cancer patients. Nevertheless, many patients have been demanding the treatment, believing it to be their last hope. At the American Society for Clinical Oncology (ASCO) annual meeting in May, other scientists reported preliminary results of an ongoing randomized clinical trial that demonstrated no survival difference between a high-dose treatment grou
'"/>

Contact: Joanna Downer
downe010@mc.duke.edu
919-684-4148
Duke University Medical Center
29-Sep-1999


Page: 1 2 3 4

Related medicine news :

1. Review supports link between HRT and stroke
2. Updated press release to October 2004 Cochrane Review
3. Rice bioengineer named to Technology Reviews TR100
4. Review of preliminary observations concludes the Mayo Clinic Natl Conf on Medicine and the Media
5. Livers From Children Are Going To Adults, University Of Pittsburgh Review Of National Data Reveals
6. Optical technique identifies vulnerable plaques in cardiac patients
7. CAS science spotlight identifies most requested article
8. Student identifies electrical changes preceding heart failure
9. Mayo Clinic identifies key cellular process in prostate and other cancers
10. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
11. Cell marker identifies patients who are more likely to respond to taxol

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2020)... ... June 26, 2020 , ... ... Inland Empire’s premier residential addiction treatment center, proudly announces that it has reopened ... special preparation for recovery in a world affected by Covid-19. , When social-distancing ...
(Date:6/28/2020)... MONTREAL (PRWEB) , ... June 27, 2020 , ... The ... cashmere folds of hundreds of rolls of toilet paper. Yet, it was the first ... hoarding seems sensible in theory. The more you have stockpiled, the less need to ...
(Date:6/28/2020)... , ... June 28, 2020 , ... ... around the world, dedicates World Allergy Week, from June 28 to July 4, ... by SARS CoV-2. , COVID-19, short for “coronavirus disease 2019”, is a disease ...
(Date:6/25/2020)... ... June 25, 2020 , ... Denials Management, Inc. has just published The Health ... filing appeals for denials of mental health and substance use disorder (MH/SUD) treatment services. ... appeal rights and explain the steps in the appeals process. Complimentary copies of ...
(Date:6/24/2020)... ... June 24, 2020 , ... At Allerio we have chosen to do things ... communications. We knew it had to be portable, it had to be reliable, it ... to work. , We are proud to announce that Allerio has passed all FCC ...
Breaking Medicine News(10 mins):
(Date:7/4/2020)... ... ... By Heidi Jean Doerfert , During this unprecedented time when the world has ... is going full speed ahead. Founders Cynthia and Thane Murphy have brought on ... wet in marketing, social media content, research, data analysis and human resources for the ...
(Date:7/2/2020)... ... July 02, 2020 , ... Gulf Coast Pharmaceuticals ... its donation of more than $190,000 in personal protective equipment (PPE) to the ... As extreme medical shortages continue to plague the nation’s communities and healthcare facilities, ...
(Date:6/28/2020)... (PRWEB) , ... June 28, 2020 , ... ... digestive health. New studies substantiate the effectiveness of oral-care probiotics to maximize ... probiotics? While the science behind both is simple – utilizing naturally occurring ...
Breaking Medicine Technology:
Cached News: